Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Bernards Rene. Director active across 1 company, notably Lixte Biotechnology Holdings, INC.. In total, 5 filings have been logged. Split: 5 buys · 0 sell. Total volume traded: €59k. History available since 14 November 2022. The latest transaction was disclosed on 2 October 2023 (Acquisition). Regulator: SEC (Form 4). All data is openly available.